OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Disease
Breast cancer
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2017
(1)
Release Date
2023
(4)
2025
(2)
2022
(2)
2018
(2)
2017
(2)
2024
(1)
2021
(1)
2016
(1)
Lab affiliation
Breast Cancer Now The Institute of Cancer Research
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study.
Not available
S-EPMC9029374
|
biostudies-literature
Cite
Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre.
Not available
S-EPMC10131438
|
biostudies-literature
Cite
Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.
Not available
S-EPMC5070760
|
biostudies-literature
Cite
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinoma.
Not available
S-EPMC12378138
|
biostudies-literature
Cite
Impact of nutritional status on pathological response and recurrence-free survival in locally advanced oesophagogastric adenocarcinoma treated with perioperative FLOT therapy.
Not available
S-EPMC12836651
|
biostudies-literature
Cite
MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients.
Not available
S-EPMC10718572
|
biostudies-literature
Cite
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study.
Not available
S-EPMC8864466
|
biostudies-literature
Cite
Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer.
Not available
S-EPMC6264798
|
biostudies-literature
Cite
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.
Not available
S-EPMC5832789
|
biostudies-literature
Cite
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE.
Not available
S-EPMC10972804
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
